HEADER HYDROLASE/HYDROLASE INHIBITOR 09-NOV-09 3KM4 TITLE OPTIMIZATION OF ORALLY BIOAVAILABLE ALKYL AMINE RENIN INHIBITORS COMPND MOL_ID: 1; COMPND 2 MOLECULE: RENIN; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ANGIOTENSINOGENASE; COMPND 5 EC: 3.4.23.15; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HUMAN_RENIN, REN; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: HEK293 CELLS; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PCDNA3.1 KEYWDS RENIN, ASPARTATE PROTEASE, HYPERTENSION, RENIN EXPRESSION, RENIN KEYWDS 2 INHIBITOR, ASPARTYL PROTEASE, CLEAVAGE ON PAIR OF BASIC RESIDUES, KEYWDS 3 DISULFIDE BOND, GLYCOPROTEIN, HYDROLASE, PROTEASE, SECRETED, KEYWDS 4 ZYMOGEN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR Z.WU,B.M.MCKEEVER REVDAT 5 06-NOV-24 3KM4 1 REMARK REVDAT 4 06-SEP-23 3KM4 1 HETSYN REVDAT 3 29-JUL-20 3KM4 1 COMPND REMARK HETNAM LINK REVDAT 3 2 1 SITE ATOM REVDAT 2 19-JUN-13 3KM4 1 JRNL VERSN REVDAT 1 12-JAN-10 3KM4 0 JRNL AUTH Z.XU,S.CACATIAN,J.YUAN,R.D.SIMPSON,L.JIA,W.ZHAO,C.M.TICE, JRNL AUTH 2 P.T.FLAHERTY,J.GUO,A.ISHCHENKO,S.B.SINGH,Z.WU,B.M.MCKEEVER, JRNL AUTH 3 B.B.SCOTT,Y.BUKHTIYAROV,J.BERBAUM,J.MASON,R.PANEMANGALORE, JRNL AUTH 4 M.G.CAPPIELLO,R.BENTLEY,C.P.DOE,R.K.HARRISON,G.M.MCGEEHAN, JRNL AUTH 5 L.W.DILLARD,J.J.BALDWIN,D.A.CLAREMON JRNL TITL OPTIMIZATION OF ORALLY BIOAVAILABLE ALKYL AMINE RENIN JRNL TITL 2 INHIBITORS. JRNL REF BIOORG.MED.CHEM.LETT. V. 20 694 2010 JRNL REFN ISSN 0960-894X JRNL PMID 19959358 JRNL DOI 10.1016/J.BMCL.2009.11.066 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 82.2 REMARK 3 NUMBER OF REFLECTIONS : 48486 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.203 REMARK 3 R VALUE (WORKING SET) : 0.200 REMARK 3 FREE R VALUE : 0.261 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2591 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.95 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3701 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 85.06 REMARK 3 BIN R VALUE (WORKING SET) : 0.2760 REMARK 3 BIN FREE R VALUE SET COUNT : 171 REMARK 3 BIN FREE R VALUE : 0.3320 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5167 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 186 REMARK 3 SOLVENT ATOMS : 462 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.11 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.39000 REMARK 3 B22 (A**2) : 2.07000 REMARK 3 B33 (A**2) : -0.68000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.198 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.187 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.114 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.874 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.950 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.917 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5489 ; 0.022 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7450 ; 2.119 ; 1.991 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 667 ; 8.015 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 222 ;35.828 ;24.144 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 857 ;16.337 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 20 ;13.319 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 831 ; 0.145 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4103 ; 0.011 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 2568 ; 0.229 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 3757 ; 0.321 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 546 ; 0.271 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 51 ; 0.259 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 20 ; 0.383 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3307 ; 1.231 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5345 ; 2.030 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2182 ; 3.200 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2105 ; 4.692 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3KM4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-NOV-09. REMARK 100 THE DEPOSITION ID IS D_1000056163. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-MAR-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 14-ID-B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9000 REMARK 200 MONOCHROMATOR : SI (111) DOUBLE-CRYSTAL REMARK 200 MONOCHROMATOR REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 62269 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.860 REMARK 200 RESOLUTION RANGE LOW (A) : 81.110 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.0 REMARK 200 DATA REDUNDANCY : 4.700 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.06600 REMARK 200 FOR THE DATA SET : 19.8600 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.86 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.95 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.3 REMARK 200 DATA REDUNDANCY IN SHELL : 4.60 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.31940 REMARK 200 FOR SHELL : 3.690 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 3D91 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.12 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.62 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M TRIS-HCL PH=7.0-8.0, 0.2M REMARK 280 (NH4)2SO4, 18-26%(W/V) PEG3350, 5MG/ML RENIN, 1MM INHIBITOR, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 278K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 26.91700 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 74.28400 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 48.47000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 74.28400 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 26.91700 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 48.47000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2810 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 27140 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -5.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER B 166 REMARK 465 GLU B 167 REMARK 465 ASN B 168 REMARK 465 SER B 169 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE1 GLN B 170 O HOH B 466 1.89 REMARK 500 O HOH B 423 O HOH B 570 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 TYR A 15 CD1 TYR A 15 CE1 -0.108 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU A 215 CA - CB - CG ANGL. DEV. = 20.7 DEGREES REMARK 500 ARG B 321 NE - CZ - NH2 ANGL. DEV. = -3.1 DEGREES REMARK 500 LEU B 338 CA - CB - CG ANGL. DEV. = 18.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 5 22.99 -142.46 REMARK 500 ASP A 17 15.45 59.61 REMARK 500 ASN A 75 -66.46 -126.59 REMARK 500 ARG A 82 64.50 -102.72 REMARK 500 THR A 312 146.67 -178.47 REMARK 500 ASN B 5 -10.19 -143.89 REMARK 500 SER B 8 135.16 -174.64 REMARK 500 ASP B 17 13.05 58.49 REMARK 500 ASN B 75 -62.80 -141.27 REMARK 500 ARG B 139 18.04 49.38 REMARK 500 ALA B 299 48.79 -85.02 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 VAL A 225 ASP A 226 -148.28 REMARK 500 THR B 6 THR B 7 148.46 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3GW5 RELATED DB: PDB REMARK 900 SAME PROTEIN CO-CRYSTALLIZED WITH A RELATED INHIBITOR REMARK 900 RELATED ID: 3D91 RELATED DB: PDB REMARK 900 SAME PROTEIN CO-CRYSTALLIZED WITH INHIBITOR, REMIKIREN DBREF 3KM4 A 4 340 UNP P00797 RENI_HUMAN 70 406 DBREF 3KM4 B 4 340 UNP P00797 RENI_HUMAN 70 406 SEQRES 1 A 337 GLY ASN THR THR SER SER VAL ILE LEU THR ASN TYR MET SEQRES 2 A 337 ASP THR GLN TYR TYR GLY GLU ILE GLY ILE GLY THR PRO SEQRES 3 A 337 PRO GLN THR PHE LYS VAL VAL PHE ASP THR GLY SER SER SEQRES 4 A 337 ASN VAL TRP VAL PRO SER SER LYS CYS SER ARG LEU TYR SEQRES 5 A 337 THR ALA CYS VAL TYR HIS LYS LEU PHE ASP ALA SER ASP SEQRES 6 A 337 SER SER SER TYR LYS HIS ASN GLY THR GLU LEU THR LEU SEQRES 7 A 337 ARG TYR SER THR GLY THR VAL SER GLY PHE LEU SER GLN SEQRES 8 A 337 ASP ILE ILE THR VAL GLY GLY ILE THR VAL THR GLN MET SEQRES 9 A 337 PHE GLY GLU VAL THR GLU MET PRO ALA LEU PRO PHE MET SEQRES 10 A 337 LEU ALA GLU PHE ASP GLY VAL VAL GLY MET GLY PHE ILE SEQRES 11 A 337 GLU GLN ALA ILE GLY ARG VAL THR PRO ILE PHE ASP ASN SEQRES 12 A 337 ILE ILE SER GLN GLY VAL LEU LYS GLU ASP VAL PHE SER SEQRES 13 A 337 PHE TYR TYR ASN ARG ASP SER GLU ASN SER GLN SER LEU SEQRES 14 A 337 GLY GLY GLN ILE VAL LEU GLY GLY SER ASP PRO GLN HIS SEQRES 15 A 337 TYR GLU GLY ASN PHE HIS TYR ILE ASN LEU ILE LYS THR SEQRES 16 A 337 GLY VAL TRP GLN ILE GLN MET LYS GLY VAL SER VAL GLY SEQRES 17 A 337 SER SER THR LEU LEU CYS GLU ASP GLY CYS LEU ALA LEU SEQRES 18 A 337 VAL ASP THR GLY ALA SER TYR ILE SER GLY SER THR SER SEQRES 19 A 337 SER ILE GLU LYS LEU MET GLU ALA LEU GLY ALA LYS LYS SEQRES 20 A 337 ARG LEU PHE ASP TYR VAL VAL LYS CYS ASN GLU GLY PRO SEQRES 21 A 337 THR LEU PRO ASP ILE SER PHE HIS LEU GLY GLY LYS GLU SEQRES 22 A 337 TYR THR LEU THR SER ALA ASP TYR VAL PHE GLN GLU SER SEQRES 23 A 337 TYR SER SER LYS LYS LEU CYS THR LEU ALA ILE HIS ALA SEQRES 24 A 337 MET ASP ILE PRO PRO PRO THR GLY PRO THR TRP ALA LEU SEQRES 25 A 337 GLY ALA THR PHE ILE ARG LYS PHE TYR THR GLU PHE ASP SEQRES 26 A 337 ARG ARG ASN ASN ARG ILE GLY PHE ALA LEU ALA ARG SEQRES 1 B 337 GLY ASN THR THR SER SER VAL ILE LEU THR ASN TYR MET SEQRES 2 B 337 ASP THR GLN TYR TYR GLY GLU ILE GLY ILE GLY THR PRO SEQRES 3 B 337 PRO GLN THR PHE LYS VAL VAL PHE ASP THR GLY SER SER SEQRES 4 B 337 ASN VAL TRP VAL PRO SER SER LYS CYS SER ARG LEU TYR SEQRES 5 B 337 THR ALA CYS VAL TYR HIS LYS LEU PHE ASP ALA SER ASP SEQRES 6 B 337 SER SER SER TYR LYS HIS ASN GLY THR GLU LEU THR LEU SEQRES 7 B 337 ARG TYR SER THR GLY THR VAL SER GLY PHE LEU SER GLN SEQRES 8 B 337 ASP ILE ILE THR VAL GLY GLY ILE THR VAL THR GLN MET SEQRES 9 B 337 PHE GLY GLU VAL THR GLU MET PRO ALA LEU PRO PHE MET SEQRES 10 B 337 LEU ALA GLU PHE ASP GLY VAL VAL GLY MET GLY PHE ILE SEQRES 11 B 337 GLU GLN ALA ILE GLY ARG VAL THR PRO ILE PHE ASP ASN SEQRES 12 B 337 ILE ILE SER GLN GLY VAL LEU LYS GLU ASP VAL PHE SER SEQRES 13 B 337 PHE TYR TYR ASN ARG ASP SER GLU ASN SER GLN SER LEU SEQRES 14 B 337 GLY GLY GLN ILE VAL LEU GLY GLY SER ASP PRO GLN HIS SEQRES 15 B 337 TYR GLU GLY ASN PHE HIS TYR ILE ASN LEU ILE LYS THR SEQRES 16 B 337 GLY VAL TRP GLN ILE GLN MET LYS GLY VAL SER VAL GLY SEQRES 17 B 337 SER SER THR LEU LEU CYS GLU ASP GLY CYS LEU ALA LEU SEQRES 18 B 337 VAL ASP THR GLY ALA SER TYR ILE SER GLY SER THR SER SEQRES 19 B 337 SER ILE GLU LYS LEU MET GLU ALA LEU GLY ALA LYS LYS SEQRES 20 B 337 ARG LEU PHE ASP TYR VAL VAL LYS CYS ASN GLU GLY PRO SEQRES 21 B 337 THR LEU PRO ASP ILE SER PHE HIS LEU GLY GLY LYS GLU SEQRES 22 B 337 TYR THR LEU THR SER ALA ASP TYR VAL PHE GLN GLU SER SEQRES 23 B 337 TYR SER SER LYS LYS LEU CYS THR LEU ALA ILE HIS ALA SEQRES 24 B 337 MET ASP ILE PRO PRO PRO THR GLY PRO THR TRP ALA LEU SEQRES 25 B 337 GLY ALA THR PHE ILE ARG LYS PHE TYR THR GLU PHE ASP SEQRES 26 B 337 ARG ARG ASN ASN ARG ILE GLY PHE ALA LEU ALA ARG MODRES 3KM4 ASN A 75 ASN GLYCOSYLATION SITE MODRES 3KM4 ASN B 75 ASN GLYCOSYLATION SITE HET NAG C 1 14 HET NAG C 2 14 HET 22X A 400 36 HET 22X A 341 36 HET NAG B 600 14 HET 22X B 400 36 HET 22X B 341 36 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM 22X (3R)-3-[(1S)-4-(ACETYLAMINO)-1-(3-CHLOROPHENYL)-1- HETNAM 2 22X HYDROXYBUTYL]-N-{(1S)-2-CYCLOHEXYL-1-[(METHYLAMINO) HETNAM 3 22X METHYL]ETHYL}PIPERIDINE-1-CARBOXAMIDE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 3 NAG 3(C8 H15 N O6) FORMUL 4 22X 4(C28 H45 CL N4 O3) FORMUL 9 HOH *462(H2 O) HELIX 1 1 TYR A 55 HIS A 61 1 7 HELIX 2 2 ASP A 65 SER A 69 5 5 HELIX 3 3 PRO A 115 MET A 120 1 6 HELIX 4 4 PHE A 132 VAL A 140 5 9 HELIX 5 5 PRO A 142 GLN A 150 1 9 HELIX 6 6 ASP A 182 GLN A 184 5 3 HELIX 7 7 SER A 235 GLY A 247 1 13 HELIX 8 8 GLU A 261 LEU A 265 5 5 HELIX 9 9 THR A 280 VAL A 285 1 6 HELIX 10 10 GLY A 316 ARG A 321 1 6 HELIX 11 11 TYR B 55 HIS B 61 1 7 HELIX 12 12 ASP B 65 SER B 69 5 5 HELIX 13 13 PRO B 115 MET B 120 1 6 HELIX 14 14 PHE B 132 VAL B 140 5 9 HELIX 15 15 PRO B 142 GLN B 150 1 9 HELIX 16 16 ASP B 182 GLN B 184 5 3 HELIX 17 17 SER B 235 GLY B 247 1 13 HELIX 18 18 GLU B 261 LEU B 265 5 5 HELIX 19 19 THR B 280 VAL B 285 1 6 HELIX 20 20 GLY B 316 LYS B 322 1 7 SHEET 1 A 9 LYS A 73 TYR A 83 0 SHEET 2 A 9 GLY A 86 VAL A 99 -1 O LEU A 92 N GLY A 76 SHEET 3 A 9 GLN A 19 ILE A 26 -1 N GLY A 25 O THR A 98 SHEET 4 A 9 SER A 8 TYR A 15 -1 N TYR A 15 O GLN A 19 SHEET 5 A 9 GLY A 174 LEU A 178 -1 O LEU A 178 N SER A 8 SHEET 6 A 9 VAL A 157 TYR A 162 -1 N SER A 159 O VAL A 177 SHEET 7 A 9 PHE A 323 ASP A 328 -1 O PHE A 327 N PHE A 158 SHEET 8 A 9 ARG A 333 ALA A 339 -1 O GLY A 335 N GLU A 326 SHEET 9 A 9 TYR A 186 ASN A 194 -1 N HIS A 191 O PHE A 336 SHEET 1 B13 LYS A 73 TYR A 83 0 SHEET 2 B13 GLY A 86 VAL A 99 -1 O LEU A 92 N GLY A 76 SHEET 3 B13 ILE A 102 GLU A 113 -1 O GLU A 110 N PHE A 91 SHEET 4 B13 VAL A 44 PRO A 47 1 N VAL A 44 O GLY A 109 SHEET 5 B13 GLY A 126 GLY A 129 -1 O VAL A 127 N TRP A 45 SHEET 6 B13 GLN A 31 ASP A 38 1 N VAL A 36 O VAL A 128 SHEET 7 B13 GLN A 19 ILE A 26 -1 N ILE A 26 O GLN A 31 SHEET 8 B13 SER A 8 TYR A 15 -1 N TYR A 15 O GLN A 19 SHEET 9 B13 GLY A 174 LEU A 178 -1 O LEU A 178 N SER A 8 SHEET 10 B13 VAL A 157 TYR A 162 -1 N SER A 159 O VAL A 177 SHEET 11 B13 PHE A 323 ASP A 328 -1 O PHE A 327 N PHE A 158 SHEET 12 B13 ARG A 333 ALA A 339 -1 O GLY A 335 N GLU A 326 SHEET 13 B13 TYR A 186 ASN A 194 -1 N HIS A 191 O PHE A 336 SHEET 1 C 4 SER A 213 LEU A 216 0 SHEET 2 C 4 GLN A 202 VAL A 210 -1 N VAL A 210 O SER A 213 SHEET 3 C 4 ILE A 268 LEU A 272 -1 O HIS A 271 N GLY A 207 SHEET 4 C 4 LYS A 275 LEU A 279 -1 O LEU A 279 N ILE A 268 SHEET 1 D 6 SER A 213 LEU A 216 0 SHEET 2 D 6 GLN A 202 VAL A 210 -1 N VAL A 210 O SER A 213 SHEET 3 D 6 CYS A 221 VAL A 225 -1 O CYS A 221 N MET A 205 SHEET 4 D 6 TRP A 313 LEU A 315 1 O LEU A 315 N LEU A 224 SHEET 5 D 6 ILE A 232 GLY A 234 -1 N SER A 233 O ALA A 314 SHEET 6 D 6 ILE A 300 ALA A 302 1 O HIS A 301 N ILE A 232 SHEET 1 E 3 LYS A 249 LYS A 250 0 SHEET 2 E 3 TYR A 255 LYS A 258 -1 O VAL A 256 N LYS A 249 SHEET 3 E 3 LEU A 295 THR A 297 -1 O CYS A 296 N VAL A 257 SHEET 1 F 9 LYS B 73 TYR B 83 0 SHEET 2 F 9 GLY B 86 VAL B 99 -1 O GLY B 86 N TYR B 83 SHEET 3 F 9 GLN B 19 ILE B 26 -1 N GLY B 25 O THR B 98 SHEET 4 F 9 SER B 8 TYR B 15 -1 N TYR B 15 O GLN B 19 SHEET 5 F 9 GLY B 174 LEU B 178 -1 O LEU B 178 N SER B 8 SHEET 6 F 9 VAL B 157 TYR B 162 -1 N TYR B 161 O GLN B 175 SHEET 7 F 9 PHE B 323 ASP B 328 -1 O PHE B 327 N PHE B 158 SHEET 8 F 9 ARG B 333 ALA B 339 -1 O GLY B 335 N GLU B 326 SHEET 9 F 9 TYR B 186 ASN B 194 -1 N HIS B 191 O PHE B 336 SHEET 1 G13 LYS B 73 TYR B 83 0 SHEET 2 G13 GLY B 86 VAL B 99 -1 O GLY B 86 N TYR B 83 SHEET 3 G13 ILE B 102 GLU B 113 -1 O GLN B 106 N ASP B 95 SHEET 4 G13 VAL B 44 PRO B 47 1 N VAL B 46 O VAL B 111 SHEET 5 G13 GLY B 126 GLY B 129 -1 O VAL B 127 N TRP B 45 SHEET 6 G13 GLN B 31 ASP B 38 1 N VAL B 36 O VAL B 128 SHEET 7 G13 GLN B 19 ILE B 26 -1 N GLY B 22 O VAL B 35 SHEET 8 G13 SER B 8 TYR B 15 -1 N TYR B 15 O GLN B 19 SHEET 9 G13 GLY B 174 LEU B 178 -1 O LEU B 178 N SER B 8 SHEET 10 G13 VAL B 157 TYR B 162 -1 N TYR B 161 O GLN B 175 SHEET 11 G13 PHE B 323 ASP B 328 -1 O PHE B 327 N PHE B 158 SHEET 12 G13 ARG B 333 ALA B 339 -1 O GLY B 335 N GLU B 326 SHEET 13 G13 TYR B 186 ASN B 194 -1 N HIS B 191 O PHE B 336 SHEET 1 H 3 GLN B 202 MET B 205 0 SHEET 2 H 3 CYS B 221 VAL B 225 -1 O ALA B 223 N ILE B 203 SHEET 3 H 3 TRP B 313 LEU B 315 1 O LEU B 315 N LEU B 224 SHEET 1 I 4 SER B 213 LEU B 216 0 SHEET 2 I 4 VAL B 208 VAL B 210 -1 N VAL B 208 O LEU B 215 SHEET 3 I 4 ILE B 268 LEU B 272 -1 O SER B 269 N SER B 209 SHEET 4 I 4 LYS B 275 LEU B 279 -1 O TYR B 277 N PHE B 270 SHEET 1 J 2 ILE B 232 GLY B 234 0 SHEET 2 J 2 ILE B 300 ALA B 302 1 O HIS B 301 N ILE B 232 SHEET 1 K 3 LYS B 249 LYS B 250 0 SHEET 2 K 3 TYR B 255 LYS B 258 -1 O VAL B 256 N LYS B 249 SHEET 3 K 3 LEU B 295 THR B 297 -1 O CYS B 296 N VAL B 257 SSBOND 1 CYS A 51 CYS A 58 1555 1555 2.03 SSBOND 2 CYS A 217 CYS A 221 1555 1555 2.09 SSBOND 3 CYS A 259 CYS A 296 1555 1555 2.02 SSBOND 4 CYS B 51 CYS B 58 1555 1555 2.02 SSBOND 5 CYS B 217 CYS B 221 1555 1555 2.08 SSBOND 6 CYS B 259 CYS B 296 1555 1555 2.10 LINK ND2 ASN A 75 C1 NAG C 1 1555 1555 1.43 LINK ND2 ASN B 75 C1 NAG B 600 1555 1555 1.62 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.45 CISPEP 1 THR A 28 PRO A 29 0 -1.51 CISPEP 2 LEU A 117 PRO A 118 0 11.27 CISPEP 3 PRO A 307 PRO A 308 0 5.71 CISPEP 4 GLY A 310 PRO A 311 0 3.05 CISPEP 5 THR B 28 PRO B 29 0 -10.30 CISPEP 6 LEU B 117 PRO B 118 0 15.54 CISPEP 7 PRO B 307 PRO B 308 0 -1.45 CISPEP 8 GLY B 310 PRO B 311 0 -5.39 CRYST1 53.834 96.940 148.568 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018576 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010316 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006731 0.00000